Literature DB >> 73082

Pathogenicity of and beta-lactamase production by Branhamella (Neisseria) catarrhalis.

A Percival, J E Corkill, J Rowlands, R B Sykes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 73082     DOI： 10.1016/s0140-6736(77)91562-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  32 in total

1.  Increase in bronchopulmonary infection due to Branhamella catarrhalis.

Authors:  L R Griffiths; S Purohit; P A Leonard
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-31

2.  Analysis of the relationship between ampicillin resistance and beta-lactamase production in Branhamella catarrhalis.

Authors:  E E Stobberingh; H J van Eck; A W Houben; C P van Boven
Journal:  Drugs       Date:  1986       Impact factor: 9.546

3.  Classification of beta-lactamases from Branhamella catarrhalis in relation to penicillinases produced by other bacterial species.

Authors:  R Labia; M Barthelemy; C B Le Bouguennec; A Buu Hoi-Dang Van
Journal:  Drugs       Date:  1986       Impact factor: 9.546

4.  Purification and properties of a beta-lactamase produced by Branhamella catarrhalis.

Authors:  E Yokota; T Fujii; K Sato; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

5.  Evaluation of a one-hour test for the identification of Neisseria species.

Authors:  R C Lairscey; M T Kelly
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

6.  BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata.

Authors:  R J Wallace; V A Steingrube; D R Nash; D G Hollis; C Flanagan; B A Brown; A Labidi; R E Weaver
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

Review 7.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

8.  Molecular characterization of the BRO beta-lactamase of Moraxella (Branhamella) catarrhalis.

Authors:  H J Bootsma; H van Dijk; J Verhoef; A Fleer; F R Mooi
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

9.  Branhamella keratitis.

Authors:  K R Wilhelmus; J Peacock; D J Coster
Journal:  Br J Ophthalmol       Date:  1980-12       Impact factor: 4.638

10.  Beta-lactamase production in Branhamella catarrhalis isolated from lower respiratory tract secretions in Danish children: an increasing problem.

Authors:  T Ejlertsen; H C Schønheyder; E Thisted
Journal:  Infection       Date:  1991 Sep-Oct       Impact factor: 3.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.